Request for Covid-19 Impact Assessment of this Report
Growth of the microalgae market can be attributed to rise in application of algal protein in dietary supplements and food industry. Moreover, algal protein is not considered an animal protein source, hence is perfect for consumption by vegan population. Furthermore, microalgae has multiple applications in cosmetics and feed industry. Both feed and cosmetics industry has experienced a surge in growth in the recent decade, which has increased demand of such products on a global level and as a resulted increase in demand for microalgae. However, uncertainties in climatic conditions leading to problems in algae production act as restraint, which hinders the market growth. On the contrary, breakthroughs in microalgae production technology and growth in adoption of microalgae in the fortified food sector is expected to provide opportunities for growth of the microalgae market in the coming years.
The Microalgae market is segmented on the basis of type, application, and region. By type, the Microalgae market is divided into Spirulina, Chlorella, Dunaliella Salina, and Aphanizomenon flos-aquae. On the basis of application, it is divided into dietary supplements, food/feed, pharmaceuticals, cosmetics, and others. Furthermore, it includes revenue generated from the sales of Microalgae across North America (the U.S., Canada, Mexico), Europe (Germany, the UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East and Africa).
Key players in the Microalgae market have adopted product launch and expansion as their key strategies to stay competitive in the market. Players profiled in the report include Algenol Biotech, Cellana Inc., Cyanotech Corporation, DIC Corporation, E.I.D Parry ltd, Fuqing King Dnarmsa Spirulina Co. Ltd., Kent BioEnergy Corporation, Taau Australia Pty Ltd., Holdings, Inc., and Astareal AB
KEY BENEFITS FOR STAKEHOLDERS
• The report provides a quantitative analysis of the current market trends, estimations, and dynamics of the market size from 2020-2028 identify the prevailing adventure tourism market opportunities.
• Porter’s five forces analysis highlights the potency of buyers and supplier’s tenable stakeholder’s make profit-oriented business decisions and strengthen their supplier–buyer network.
• In-depth analysis of the size and segmentation assists in determining the prevailing market opportunities.
• The major countries in each region are mapped according their revenue contribution the industry.
• The market player positioning segment facilitates benchmarking and provides a clear understanding of the present position of the market players in the industry.
KEY MARKET SEGMENTATION
• By Type
o Spirulina
o Chlorella
o Dunaliella Salina
o Aphanizomenon Flos-Aquae
• By Application
o Dietary supplements
o Food/Feed
o Pharmaceutical
o Cosmetic
o Others
• By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
UK
France
Italy
Spain
Rest of Europe
o Asia-Pacific
China
India
Japan
South Korea
Australia
Rest of Asia-Pacific
o LAMEA
Latin America
Middle East
Africa
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.5.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Microalgae market snapshot
2.2.Key findings of the study
2.3.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Multiple benefits of micro-algal protein to amplify market growth
3.4.1.2.Increase in vegan population to strengthen product adoption
3.4.1.3.High protein concentration as compared to counter parts
3.4.2.Restraints
3.4.2.1.Impact on spirulina production due to climate change
3.4.2.2.Presence of large number of alternatives for protein, along with low product awareness
3.4.3.Opportunities
3.4.3.1.Novel innovations in technology to provide lucrative opportunities for market expansion
3.4.3.2.Algae protein fortified food to gain significant traction in upcoming years
3.5.COVID-19 impact analysis
3.5.1.Introduction
3.5.2.Impact on Microalgae market
3.6.Value Chain Analysis
3.7.Top Impacting factors
CHAPTER 4:MICROALGAE MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Spirulina
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market size and forecast, by country
4.3.Chlorella
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market size and forecast, by country
4.4.Dunaliella Salina
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market size and forecast, by country
4.5.Aphanizomenon Flos-Aquae
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market size and forecast, by country
CHAPTER 5:MICROALGAE MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
Dietary Supplements
5.1.2.Key market trends, growth factors, and opportunities
5.1.3.Market size and forecast, by region
5.1.4.Market size and forecast, by country
5.2.Food/Feed
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market size and forecast, by country
5.3.Pharmaceutical
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market size and forecast, by country
5.4.Cosmetic
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market size and forecast, by country
5.5.Others
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by region
5.5.3.Market size and forecast, by country
CHAPTER 6:MICROALGAE MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast, by region
6.2.North America
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by type
6.2.3.Market size and forecast, by application
6.2.4.Market size and forecast, by country
6.2.5.U.S.
6.2.5.1.Market size and forecast, by type
6.2.5.2.Market size and forecast, by application
6.2.6.Canada
6.2.6.1.Market size and forecast, by type
6.2.6.2.Market size and forecast, by application
6.2.7.Mexico
6.2.7.1.Market size and forecast, by type
6.2.7.2.Market size and forecast, by application
6.3.Europe
6.3.1.Key market trends, growth factors, and opportunities
6.3.3.Market size and forecast, by type
6.3.4.Market size and forecast, by application
6.3.5.Market size and forecast, by country
6.3.6.Germany
6.3.6.1.Market size and forecast, by type
6.3.6.2.Market size and forecast, by application
6.3.7.UK
6.3.7.1.Market size and forecast, by type
6.3.7.2.Market size and forecast, by application
6.3.8.France
6.3.8.1.Market size and forecast, by type
6.3.8.2.Market size and forecast, by application
6.3.9.Italy
6.3.9.1.Market size and forecast, by type
6.3.9.2.Market size and forecast, by application
6.3.10.Spain
6.3.10.1.Market size and forecast, by type
6.3.10.2.Market size and forecast, by application
6.3.11.Rest of Europe
6.3.11.1.Market size and forecast, by type
6.3.11.2.Market size and forecast, by application
6.4.Asia-Pacific
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by type
6.4.3.Market size and forecast, by application
6.4.4.Market size and forecast, by country
6.4.5.China
6.4.5.1.Market size and forecast, by type
6.4.5.2.Market size and forecast, by application
6.4.6.India
6.4.6.1.Market size and forecast, by type
6.4.6.2.Market size and forecast, by application
6.4.7.Japan
6.4.7.1.Market size and forecast, by type
6.4.7.2.Market size and forecast, by application
6.4.8.South Korea
6.4.8.1.Market size and forecast, by type
6.4.8.2.Market size and forecast, by application
6.4.9.Australia
6.4.9.1.Market size and forecast, by type
6.4.9.2.Market size and forecast, by application
6.4.10.Rest of Asia-Pacific
6.4.10.1.Market size and forecast, by type
6.4.10.2.Market size and forecast, by application
6.5.LAMEA
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by type
6.5.3.Market size and forecast, by application
6.5.5.Market size and forecast, by country
6.5.6.Latin America
6.5.6.1.Market size and forecast, by type
6.5.6.2.Market size and forecast, by application
6.5.7.Middle East
6.5.7.1.Market size and forecast, by type
6.5.7.2.Market size and forecast, by application
6.5.8.Africa
6.5.8.1.Market size and forecast, by type
6.5.8.2.Market size and forecast, by application
CHAPTER 7:COMPETITION LANDSCAPE
7.1.Top winning strategies
7.2.Competitive dashboard
7.3.Competitive heat map
7.4.Key developments
7.4.1.Business Expansion
7.4.2.Partnership
7.4.3.Agreement
7.4.4.Product Launch
CHAPTER 8:COMPANY PROFILES
8.1.Introduction
8.2.ALGENOL BIOTECH
8.2.1.Company overview
8.2.2.Key Executive
8.2.3.Company snapshot
8.2.4.Product portfolio
8.3.CELLANA, INC.
8.3.1.Company overview
8.3.2.Key Executives
8.3.3.Company snapshot
8.3.4.Product portfolio
8.3.5.Key strategic moves and developments
8.4.CYANOTECH CORPORATION
8.4.1.Company overview
8.4.2.Key Executives
8.4.3.Company snapshot
8.4.4.Operating business segments
8.4.5.Product portfolio
8.4.6.R&D Expenditure
8.4.7.Business performance
8.4.8.Key strategic moves and developments
8.5.DIC CORPORATION
8.5.1.Company overview
8.5.2.Key Executives
8.5.3.Company snapshot
8.5.4.Operating business segments
8.5.5.Product portfolio
8.5.6.R&D Expenditure
8.5.7.Business performance
8.6.FUQING KING DNARMSA SPIRULINA CO., LTD.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Product portfolio
8.7.TERRAVIA HOLDINGS, INC.
8.7.1.Company overview
8.7.2.Key Executives
8.7.3.Company snapshot
8.7.4.Operating business segments
8.7.5.Product portfolio
8.7.6.Business performance
8.8.ASTAREAL AB
8.8.1.Company overview
8.8.2.Key Executives
8.8.3.Company snapshot
8.8.4.Product portfolio
8.9.NECTON SA
8.9.1.Company overview
8.9.2.Key Executives
8.9.3.Company snapshot
8.9.4.Product portfolio
8.10.ROYAL DSM OCEAN NUTRITION
8.10.1.Company overview
8.10.2.Key Executives
8.10.3.Company snapshot
8.10.4.Operating business segments
8.10.5.Product portfolio
8.10.6.Business performance
8.11.BIOPROCESS ALGAE LLC
8.11.1.Company overview
8.11.2.Key Executives
8.11.3.Company snapshot
8.11.4.Product portfolio
TABLE 01.MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 02.SPIRULINA MICROALGAE MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 03.CHLORELLA MICROALGAE MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 04.DUNALIELLA SALINA MICROALGAE MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 05.APHANIZOMENON FLOS-AQUAE MICROALGAE MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 06.MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 07.MICROALGAE MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2020–2028 ($MILLION)
TABLE 08.MICROALGAE MARKET FOR FOOD/FEED, BY REGION, 2020–2028 ($MILLION)
TABLE 09.MICROALGAE MARKET FOR PHARMACEUTICAL, BY REGION, 2020–2028 ($MILLION)
TABLE 10.MICROALGAE MARKET FOR COSMETIC, BY REGION, 2020–2028 ($MILLION)
TABLE 11.MICROALGAE MARKET FOR OTHERS, BY REGION, 2020–2028 ($MILLION)
TABLE 12.MICROALGAE MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 13.NORTH AMERICA MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 14.NORTH AMERICA MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 15.NORTH AMERICA MICROALGAE MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 16.U.S. MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 17.U.S. MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 18.CANADA MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 19.CANADA MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 20.MEXICO MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 21.MEXICO MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 22.EUROPE MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 23.EUROPE MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 24.EUROPE MICROALGAE MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 25.GERMANY MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 26.GERMANY MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 27.UK MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 28.UK MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 29.FRANCE MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 30.FRANCE MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 31.ITALY MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 32.ITALY MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 33.SPAIN MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 34.SPAIN MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 35.REST OF EUROPE MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 36.REST OF EUROPE MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 37.ASIA-PACIFIC MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 38.ASIA-PACIFIC MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 39.ASIA-PACIFIC MICROALGAE MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 40.CHINA MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 41.CHINA MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 42.INDIA MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 43.INDIA MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 44.JAPAN MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 45.JAPAN MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 46.SOUTH KOREA MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 47.SOUTH KOREA MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 48.AUSTRALIA MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 49.AUSTRALIA MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 50.REST OF ASIA-PACIFIC MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 51.REST OF ASIA-PACIFIC MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 52.LAMEA MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 53.LAMEA MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 54.LAMEA MICROALGAE MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 55.LATIN AMERICA MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 56.LATIN AMERICA MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 57.MIDDLE EAST MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 58.MIDDLE EAST MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 59.AFRICA MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 60.AFRICA MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 61.ALGENOL BIOTECH: KEY EXECUTIVE
TABLE 62.ALGENOL BIOTECH: COMPANY SNAPSHOT
TABLE 63.ALGENOL BIOTECH: PRODUCT PORTFOLIO
TABLE 64.CELLANA, INC.: KEY EXECUTIVES
TABLE 65.CELLANA, INC.: COMPANY SNAPSHOT
TABLE 66.CELLANA, INC.: PRODUCT PORTFOLIO
TABLE 67.CYANOTECH CORPORATION : KEY EXECUTIVES
TABLE 68.CYANOTECH CORPORATION : COMPANY SNAPSHOT
TABLE 69.CYANOTECH CORPORATION : OPERATING SEGMENTS
TABLE 70.CYANOTECH CORPORATION : PRODUCT PORTFOLIO
TABLE 71.CYANOTECH CORPORATION : R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 72.CYANOTECH CORPORATION : NET SALES, 2018–2020 ($MILLION)
TABLE 73.DIC CORPORATION: KEY EXECUTIVES
TABLE 74.DIC CORPORATION: COMPANY SNAPSHOT
TABLE 75.DIC CORPORATION: OPERATING SEGMENTS
TABLE 76.DIC CORPORATION: PRODUCT PORTFOLIO
TABLE 77.DIC CORPORATION: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 78.DIC CORPORATION: NET SALES, 2018–2020 ($MILLION)
TABLE 79.FUQING KING DNARMSA SPIRULINA CO., LTD. : COMPANY SNAPSHOT
TABLE 80.FUQING KING DNARMSA SPIRULINA CO., LTD. : PRODUCT PORTFOLIO
TABLE 81.TERRAVIA HOLDINGS, INC.: KEY EXECUTIVES
TABLE 82.TERRAVIA HOLDINGS, INC.: COMPANY SNAPSHOT
TABLE 83.TERRAVIA HOLDINGS, INC.: OPERATING SEGMENTS
TABLE 84.TERRAVIA HOLDINGS, INC.: PRODUCT PORTFOLIO
TABLE 85.TERRAVIA HOLDINGS, INC.: NET SALES, 2018–2020 ($MILLION)
TABLE 86.ASTAREAL AB: KEY EXECUTIVES
TABLE 87.ASTAREAL AB: COMPANY SNAPSHOT
TABLE 88.ASTAREAL AB: PRODUCT PORTFOLIO
TABLE 89.NECTON SA: KEY EXECUTIVES
TABLE 90.NECTON SA: COMPANY SNAPSHOT
TABLE 91.NECTON SA: PRODUCT PORTFOLIO
TABLE 92.ROYAL DSM : KEY EXECUTIVES
TABLE 93.ROYAL DSM : COMPANY SNAPSHOT
TABLE 94.ROYAL DSM : OPERATING SEGMENTS
TABLE 95.ROYAL DSM : PRODUCT PORTFOLIO
TABLE 96.ROYAL DSM : NET SALES, 2018–2020 ($MILLION)
TABLE 97.BIOPROCESS ALGAE LLC: KEY EXECUTIVES
TABLE 98.BIOPROCESS ALGAE LLC: COMPANY SNAPSHOT
TABLE 99.BIOPROCESS ALGAE LLC: PRODUCT PORTFOLIO
According to FAO, aquaculture, also known as aqua farming, is defined as the farming of aquatic organisms such as fish, mollusks, crustaceans, and aquatic plants. Farming implies intervention in the rearing process to enhance production, such as regular stocki...
In the year 2015, the global organic food and beverages market accounted for $115,984 million, and is estimated to grow at a CAGR of 16.4% to reach $327,600 million by 2022. Organic foods are produced by organic farming, which uses natural fertilizers and trad...
Animal nutrition chemicals are supplements given to animals that corrects deficiencies in feed and dietary supplementation. In addition, animal nutrition chemicals improve animal’s immunity, pregnancy outcome, fertility, newborn survival and growth, meat...